Epithelioid glioblastoma with microglia features: potential for novel therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epithelioid glioblastoma with microglia features: potential for novel therapy
Authors
Keywords
-
Journal
BRAIN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-21
DOI
10.1111/bpa.12887
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy
- (2019) Yu Kanemaru et al. Acta Neuropathologica Communications
- NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth
- (2019) Tamer S. Kaoud et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment
- (2019) Ewelina Dratkiewicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
- (2018) Garry Ceccon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rapid Clinical and Radiographic Response With Combined Dabrafenib and Trametinib in Adults With BRAF -Mutated High-Grade Glioma
- (2018) Tanner M. Johanns et al. Journal of the National Comprehensive Cancer Network
- Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAFV600E mutation
- (2018) Kai Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The therapeutic potential of targeting the BRAF mutation in patients with colorectal cancer
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular imaging of nestin in neuroinflammatory conditions reveals marked signal induction in activated microglia
- (2017) Senthil Krishnasamy et al. Journal of Neuroinflammation
- The aPKC-CBP Pathway Regulates Post-stroke Neurovascular Remodeling and Functional Recovery
- (2017) Ayden Gouveia et al. Stem Cell Reports
- Cell of origin of glioma: biological and clinical implications
- (2016) Sheila R Alcantara Llaguno et al. BRITISH JOURNAL OF CANCER
- Epithelial-mesenchymal transition in glioblastoma progression
- (2016) YASUO IWADATE Oncology Letters
- Isolation of highly enriched primary human microglia for functional studies
- (2016) Justin Rustenhoven et al. Scientific Reports
- Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas-Same Entity or First Cousins?
- (2015) Sanda Alexandrescu et al. BRAIN PATHOLOGY
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival
- (2013) Jian Luo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways
- (2013) Katrin Kierdorf et al. NATURE NEUROSCIENCE
- Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells
- (2013) V Barbetti et al. ONCOGENE
- Clinical Responses to Vemurafenib in Patients with Metastatic Papillary Thyroid Cancer Harboring BRAFV600E Mutation
- (2013) Kevin B. Kim et al. THYROID
- Importance of direct macrophage - Tumor cell interaction on progression of human glioma
- (2012) Yoshihiro Komohara et al. CANCER SCIENCE
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
- (2012) Gerald S Falchook et al. LANCET
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sleeping Beauty–Mediated Somatic Mutagenesis Implicates CSF1 in the Formation of High-Grade Astrocytomas
- (2010) Aaron M. Bender et al. CANCER RESEARCH
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- The Glial Nature of Embryonic and Adult Neural Stem Cells
- (2009) Arnold Kriegstein et al. Annual Review of Neuroscience
- Isolation and characterization of neural stem/progenitor cells from post-stroke cerebral cortex in mice
- (2009) Takayuki Nakagomi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Endothelial Cells Support Survival, Proliferation, and Neuronal Differentiation of Transplanted Adult Ischemia-Induced Neural Stem/Progenitor Cells After Cerebral Infarction
- (2009) Nami Nakagomi et al. STEM CELLS
- Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma
- (2008) Fausto J. Rodriguez et al. CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now